Cancer Care Specialists of Central IL

Effingham, Illinois 62401

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Metastases, Non Small Cell Lung Carcinoma

Studies at this site

• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed